Lung Cancer Leads in Global Cancer Mortality for Ten Years

Lung cancer has become the most common and lethal cancer globally, remaining the leading cause of cancer-related deaths for a decade, as reported by the latest data from the International Agency for Research on Cancer. Globally, around four...

Lung Cancer Leads in Global Cancer Mortality for Ten Years
Lung cancer has become the most common and lethal cancer globally, remaining the leading cause of cancer-related deaths for a decade, as reported by the latest data from the International Agency for Research on Cancer.

Globally, around four to five people are diagnosed with lung cancer every minute, while three to four individuals die from the disease within the same period.

As the burden of lung cancer grows, public health strategies focusing on prevention, accessible screening, and innovative treatments provide hope for reversing this alarming trend.

In an interview with China Media Group, Chen Keneng, director of thoracic surgery at Beijing Cancer Hospital, pointed to the decade-long increase in lung cancer cases as a result of rapid lifestyles, industrialization, increased stress, and rising smoking rates in developing nations.

According to the National Cancer Center of China, there were more than 1.06 million new lung cancer cases and 730,000 deaths in 2022, with both incidence and mortality rates being the highest among all cancers.

April 15 marks the beginning of China's National Anti-Cancer Week, during which numerous events will be held to raise awareness about cancer prevention and treatment.

Early detection is critical

Lung cancer is preventable, and patients diagnosed at early stages have high cure rates. Experts emphasize that early detection, diagnosis, and treatment are essential in battling this disease.

Before 2012, chest X-rays served as the primary screening method in China, but the introduction of low-dose spiral CT scans has raised early detection rates to 90 percent.

Chen noted that lung cancer often shows no symptoms in its early stages, urging high-risk groups, like long-term smokers and individuals with family histories, to undergo annual CT screenings.

Experts also warn that low-dose CT scans expose patients to radiation risks, advising against annual screenings for individuals who are not considered high-risk.

Smoking is the leading preventable cause of lung cancer. Research indicates that quitting smoking for a decade can reduce the risk of lung cancer by over 50 percent.

China has bolstered community-level lung cancer screening programs, with Beijing incorporating these initiatives into chronic disease management frameworks, benefiting more than a million residents.

Patients with ground-glass opacity nodules in early-stage cases can expect nearly 100 percent survival rates over 5 to 10 years, while those diagnosed with stage I solid tumors have 5-year survival rates of 70 to 80 percent.

Significant advancements in targeted therapies and immunotherapies have markedly improved survival rates for patients with advanced-stage lung cancer. Additionally, multidisciplinary collaboration models within hospitals have enhanced treatment outcomes even further.

Jessica Kline for TROIB News

Discover more Science and Technology news updates in TROIB Sci-Tech